Lexicon Genetics Awarded Additional Grant for Study of Spinal Muscular Atrophy(10/13/2006) Lexicon Genetics Incorporated announced that its research program to identify targets that may be important in the development of drugs to prevent or treat spinal muscular atrophy (SMA) has been extended for an additional year by the United States ...